KPT Industries appoints Dr. Nitin Vikas Pai as Non-Executive Director
KPT Industries Limited has appointed Dr. Nitin Vikas Pai as a Non-Executive Director effective May 29, 2026. The Board approved the appointment at its meeting held on Friday. Dr. Pai is a senior gastroenterologist at Ruby Hall Clinic and is related to the Non-Executive Chairperson.

*this image is generated using AI for illustrative purposes only.
KPT Industries Limited has appointed Dr. Nitin Vikas Pai as a Non-Executive Director effective May 29, 2026. The Board of Directors approved the appointment during its meeting held on Friday. Dr. Pai will serve in the role and is liable to retire by rotation.
Dr. Nitin Vikas Pai is 52 years old and brings extensive medical expertise to the board. He is a Pune-based senior gastroenterologist and currently serves as the Director of Gastroenterology at Ruby Hall Clinic, a tertiary care institution. His educational qualifications include MD Medicine, DNB Medicine, and DM Gastroenterology.
The disclosure regarding the appointment was made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that Dr. Pai is not debarred from holding office by any regulatory authority.
A relationship disclosure indicates that Dr. Nitin Pai is the nephew of Late Mr. Prakash Kulkarni and Mrs. Prabha Kulkarni, the Non-Executive Chairperson. The company stated that Dr. Pai does not come under the purview of section 2(76) or 2(77).
Details of Appointment
| Particulars | Details |
|---|---|
| Name of Director | Dr. Nitin Vikas Pai |
| Designation | Non-Executive Director |
| Date of Appointment | May 29, 2026 |
| Age | 52 years |
| Qualification | MD Medicine, DNB Medicine, DM Gastroenterology |
| Current Role | Director of Gastroenterology, Ruby Hall Clinic |
Historical Stock Returns for KPT Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.08% | +8.26% | -1.70% | -16.41% | -29.81% | +242.86% |
How will Dr. Pai's medical expertise influence KPT Industries' strategic direction?
Could this appointment signal a potential expansion into healthcare-related sectors?
What specific governance contributions is the board expecting from Dr. Pai?


































